Clinical Trial Update: Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) [NA]

View source ↗

Summary

A clinical trial update shows ongoing recruitment for an individualized mRNA neoantigen vaccine, mRNA-0523-L001, to treat several advanced endocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma
• Medullary Thyroid Carcinoma
• Pancreatic Neuroendocrine Tumor
• Thymic Neuroendocrine Carcinoma

Drugs mentioned

• mRNA-0523-L001

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Adrenal Cortical Carcinoma, Medullary Thyroid Cancer | NA | Status: RECRUITING